United Statespulmonaryfibrosis.org
The Pulmonary Fibrosis Foundation is a U.S.-based nonprofit organization focused on improving outcomes for people living with pulmonary fibrosis (PF), including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). The foundation advances research, clinical education, and advocacy to accelerate diagnosis, enhance care, and expand evidence on PF and related interstitial lung diseases.
PFF leads national programs such as the PFF Care Center Network, supports research through patient registries and grants, and provides resources for patients, caregivers, and healthcare professionals. It convenes multidisciplinary stakeholders through scientific meetings and professional education and collaborates with academic centers and industry partners to facilitate clinical studies and best-practice adoption across the PF community.
None yet. When a new project in the record names Pulmonary Fibrosis Foundation as owner, partner or investor, it shows here.
JASCAYD, a PDE4B inhibitor, slows lung function decline in progressive pulmonary fibrosis, offering a new treatment option based on Phase III trial results.
